Your browser doesn't support javascript.
Impact of COVID-19 pandemic on functional urology procedures in France: a prospective study.
Guillot-Tantay, Cyrille; Robert, Grégoire; Ruffion, Alain; Gamé, Xavier; Balanca, Astrid; Cousin, Tiffany; Campello, Pierre-Vincent; Simon, Jeanne; Baron, Maximilien; Fleury, Raphael; Dequirez, Pierre-Luc; Davidson, Sypre; Joussain, Charles; Vangheluwe, Lucie; Anastay, Vassily; Léon, Priscilla; Perrouin-Verbe, Marie-Aimée; Peyronnet, Benoit; Biardeau, Xavier; Cornu, Jean-Nicolas; Karsenty, Gilles; Phé, Véronique.
  • Guillot-Tantay C; Department of Urology, Sorbonne Université, Assistance Publique - Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Academic Hospital, 47-83 boulevard de l'hôpital, 75013, Paris, France.
  • Robert G; Department of Urology, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Ruffion A; Department of Urology, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.
  • Gamé X; Department of Urology, Centre Hospitalier Universitaire de Rangueil, Toulouse, France.
  • Balanca A; Department of Neuro-Urology, Assistance-Publique-Hôpitaux de Paris (AP-HP), Raymond Poincaré Academic Hospital, Garches, France.
  • Cousin T; Department of Urology, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Campello PV; Department of Urology, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.
  • Simon J; Department of Urology, Centre Hospitalier Universitaire de Rangueil, Toulouse, France.
  • Baron M; Department of Urology, Nantes Academic Hospital, Hôtel Dieu, Nantes, France.
  • Fleury R; Centre Hospitalier Universitaire de Rennes, Service d'urologie, Rennes, France.
  • Dequirez PL; Department of Urology, Lille Academic Hospital, Claude Huriez Hospital, Lille, France.
  • Davidson S; Department of Urology, Lille Academic Hospital, Claude Huriez Hospital, Lille, France.
  • Joussain C; Department of Neuro-Urology, Assistance-Publique-Hôpitaux de Paris (AP-HP), Raymond Poincaré Academic Hospital, Garches, France.
  • Vangheluwe L; Department of Urology, Centre Hospitalier Universitaire Rouen, Rouen, France.
  • Anastay V; Department of Urology, Assistance-Publique-Hôpitaux de Marseille (AP-HM), La Conception Hospital, Marseille, France.
  • Léon P; Urology Department, Pasteur Clinic, Paris, France.
  • Perrouin-Verbe MA; Department of Urology, Nantes Academic Hospital, Hôtel Dieu, Nantes, France.
  • Peyronnet B; Centre Hospitalier Universitaire de Rennes, Service d'urologie, Rennes, France.
  • Biardeau X; Department of Urology, Lille Academic Hospital, Claude Huriez Hospital, Lille, France.
  • Cornu JN; Department of Urology, Centre Hospitalier Universitaire Rouen, Rouen, France.
  • Karsenty G; Department of Urology, Assistance-Publique-Hôpitaux de Marseille (AP-HM), La Conception Hospital, Marseille, France.
  • Phé V; Department of urology, Sorbonne Université, Assistance Publique - Hôpitaux de Paris, Tenon Academic Hospital, Paris, France. veronique.phe@aphp.fr.
World J Urol ; 40(1): 277-282, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1391852
ABSTRACT

PURPOSE:

To evaluate the impact of COVID-19 pandemic on functional urology procedures in France.

METHODS:

A prospective study was conducted within 11 secondary and tertiary referral centers in France. Patients aged > 18 years who were diagnosed with a functional urology disease before the national lockdown (March 17th, 2020) and who required a surgery were included. Study period went from March 17th to September 30th 2020. The included interventions were listed according to the guidelines for functional urology enacted by the French Association of Urology and delay of reoperation was compared to the guidelines' delay. The primary outcome was the number of procedures left unscheduled at the end of the study period. Descriptive statistics were performed.

RESULTS:

From March 17th 2020 to September 3 rd 2020, 1246 patients with a previous diagnosis of a functional urological disease requiring a surgery were included. The mean follow-up was 140.4 days (± 53.4). Overall, 316 interventions (25.4%) were maintained whereas 74 (5.9%) were canceled, 848 (68.1%) postponed and 8 patients (0.6%) died. At the end of the follow-up, 184 patients (21.7%) were still not rescheduled. If the intervention was postponed, the mean delay between the initial and final date was 85.7 days (± 64.4).

CONCLUSION:

Overall, more than two thirds of interventions had to be postponed and the mean delay between the initial and final date was about three months.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urologic Surgical Procedures / Urologic Diseases / Time-to-Treatment / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: World J Urol Year: 2022 Document Type: Article Affiliation country: S00345-021-03821-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Urologic Surgical Procedures / Urologic Diseases / Time-to-Treatment / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: World J Urol Year: 2022 Document Type: Article Affiliation country: S00345-021-03821-3